Sentence examples for improved length from inspiring English sources

Although these may be markers of beneficial effects on patient-oriented outcomes (e.g. arterial calcification may be linked to a reduction in cardiovascular morbidity and mortality), in themselves they do not demonstrate improved length or quality of life.

In a further study of 99 US patients, adherence to IDSA guidelines significantly improved length of stay from 6.8 to 4.5 days (P < 0.01) and resulted in lower hospital costs (P < 0.05) [ 44].

Two randomized trials showed that second-line CPT-11 in patients with metastatic colorectal cancer improved length and quality of life compared to best supportive care [ 12] as well as alternative fluoropyrimidine-based regimens [ 13].

ClinicalTrials.gov number, NCT00932334 Living related kidney transplantation (LKT) represents an optimal strategy for the treatment of patients with end stage renal disease (ESRD), offering recipients substantially improved length and quality of life when compared to patients receiving dialysis [ 1].

This evaluation will primarily be based on cost-benefit analyses comparing the costs incurred by the new treatments with the benefits obtained, measured as improved length of life and quality of life and the savings obtained from reduced costs in the health-care system due to fewer patients with severe complications.

The improved length and accuracy of reads obtained from Sanger sequencing can complement NGS workflows.

Because prostate cancer is usually slow growing, doctors also do not know whether treating the cancer early, when confined to the prostate, improves length or quality of life compared with close monitoring.

To improve length and quality, the resulting contigs were further assembled with TGICL.

Primary total knee operations have been used in this study as an example group that has a high profile in the area of improving length of stay nationally.

Compared to traditional FPs, GIM-Hospitalists appear to improve length of stay [OR−2.975, (CI −3.302 – -2.647)] while FP-Hospitalists perform similarly [OR 0.096, (CI −0.136 – 0.329)].

Our focus on babies was essential in the context of the SHINE trial primary aims of improving length and hemoglobin concentration (or reducing stunting and anemia, respectively) at 18 months [ 9].